Showing results (351-360 of 627) with videos related to

Sort By:
Pageof 63
BJU International|April 22, 2006
Clinical characteristics of bladder cancer in patients previously treated with radiation for prostate cancerJaspreet S Sandhu, Andrew J Vickers, Bernard Bochner, et al.
The Journal of Urology|February 25, 1998
Clinical stage I testis cancer: long-term outcome of patients on surveillanceP C Sogani, M Perrotti, H W Herr, et al.
The Journal of Urology|August 1, 1994
Positive urinary cytology following a complete response to intravesical bacillus Calmette-Guerin therapy: pattern of recurrenceM D Schwalb, H W Herr, P C Sogani, et al.
International Journal of Hygiene and Environmental Health|October 9, 2013
Assessing the environmental health relevance of cooling towers--a systematic review of legionellosis outbreaksSandra M Walser, Doris G Gerstner, Bernhard Brenner, et al.
The Journal of Urology|July 4, 2006
Safety and efficacy of intravesical bacillus Calmette-Guerin instillations in steroid treated and immunocompromised patientsOfer Yossepowitch, Scott E Eggener, Bernard H Bochner, et al.
The Journal of Urology|October 16, 2007
Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survivalZohar A Dotan, Kathryn Kavanagh, Ofer Yossepowitch, et al.
BJU International|April 7, 2010
Variability of treatment selection among surgeons for patients with cT1 urothelial carcinomaGuido Dalbagni, Matthew Kaag, Angel Cronin, et al.
BJU International|December 13, 2006
Prospective evaluation of p53 as a prognostic marker in T1 transitional cell carcinoma of the bladderGuido Dalbagni, Dipen J Parekh, Leah Ben-Porat, et al.
European Urology|July 28, 2009
Clinical outcome in a contemporary series of restaged patients with clinical T1 bladder cancerGuido Dalbagni, Kinjal Vora, Matthew Kaag, et al.
Cancer Research|April 15, 1988
Anticarcinoma activity of rhodamine 123 against a murine renal adenocarcinomaH W Herr, J L Huffman, R Huryk, et al.
Pageof 63